IT1261955B - Soluzione di farmaci in particolare piroxicam con stabilita' aumentatae senza effetto dannoso sui tessuti e procedimento per la loro preparazione - Google Patents

Soluzione di farmaci in particolare piroxicam con stabilita' aumentatae senza effetto dannoso sui tessuti e procedimento per la loro preparazione

Info

Publication number
IT1261955B
IT1261955B ITMI913171A ITMI913171A IT1261955B IT 1261955 B IT1261955 B IT 1261955B IT MI913171 A ITMI913171 A IT MI913171A IT MI913171 A ITMI913171 A IT MI913171A IT 1261955 B IT1261955 B IT 1261955B
Authority
IT
Italy
Prior art keywords
piroxicam
increased stability
fabrics
drugs
procedure
Prior art date
Application number
ITMI913171A
Other languages
English (en)
Inventor
Margit Nata Kricsfalussy Nagy
Original Assignee
Margit Nata Kricsfalussy Nagy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Margit Nata Kricsfalussy Nagy filed Critical Margit Nata Kricsfalussy Nagy
Publication of ITMI913171A0 publication Critical patent/ITMI913171A0/it
Publication of ITMI913171A1 publication Critical patent/ITMI913171A1/it
Application granted granted Critical
Publication of IT1261955B publication Critical patent/IT1261955B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

L'invenzione riguarda originali soluzioni di piroxicam di stabilità aumentata e senza effetto di danneggiamento dei tessuti, particolarmente soluzioni che possono essere usate come soluzioni iniettabili o gocce oftalmiche. La soluzione secondo la presente invenzione comprende da 1 a 5% in peso di 4-idrossi-2-metil N-(2-piridil)-2H-1, 2-benzotiazina-3-carbossammide-1, 1-diossido, da 0,5 a 5,0% in peso di sodioglicina carbossilato nonché da 0,5 a 12% in peso di additivo o additivi. L'invenzione riguarda inoltre un procedimento per la preparazione delle suddette soluzioni.
ITMI913171A 1990-11-27 1991-11-27 Soluzione di farmaci in particolare piroxicam con stabilita' aumentatae senza effetto dannoso sui tessuti e procedimento per la loro preparazione IT1261955B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU907654A HU205550B (en) 1990-11-27 1990-11-27 Process for producing pyroxycam solution of increased stability, free from effects damaging tussues

Publications (3)

Publication Number Publication Date
ITMI913171A0 ITMI913171A0 (it) 1991-11-27
ITMI913171A1 ITMI913171A1 (it) 1992-05-28
IT1261955B true IT1261955B (it) 1996-06-11

Family

ID=10972319

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI913171A IT1261955B (it) 1990-11-27 1991-11-27 Soluzione di farmaci in particolare piroxicam con stabilita' aumentatae senza effetto dannoso sui tessuti e procedimento per la loro preparazione

Country Status (13)

Country Link
US (1) US5169847A (it)
JP (1) JPH04275222A (it)
AT (1) AT397462B (it)
CY (1) CY1800A (it)
CZ (1) CZ281142B6 (it)
DE (1) DE4139017C2 (it)
GB (1) GB2250197B (it)
HU (1) HU205550B (it)
IT (1) IT1261955B (it)
MY (1) MY108601A (it)
RO (1) RO113303B1 (it)
RU (1) RU2062616C1 (it)
SK (1) SK278929B6 (it)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
ATE259220T1 (de) 1998-05-29 2004-02-15 Skyepharma Canada Inc Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben
SK288117B6 (sk) 1998-11-20 2013-09-03 Skyepharma Canada Inc. Rapidly dispersing solid dry therapeutic dosage form
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US8586094B2 (en) 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
GB2404336A (en) * 2003-07-30 2005-02-02 Cipla Ltd Stabilisation of therapeutic agents using a carbonate salt of an amino acid, preferably in the presence of a saccharide, & pharmaceutical compositions thereof
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
JP2009510007A (ja) * 2005-09-30 2009-03-12 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む医薬調製
CN102647971B (zh) 2009-10-12 2016-03-16 贝林格尔.英格海姆维特梅迪卡有限公司 用于包含美洛昔康的组合物的容器
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
AU2010347598B2 (en) 2010-03-03 2014-11-27 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3217315C2 (de) * 1982-05-08 1986-05-22 Gödecke AG, 1000 Berlin Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten
IT1216686B (it) * 1988-04-01 1990-03-08 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.

Also Published As

Publication number Publication date
GB9125268D0 (en) 1992-01-29
RO113303B1 (ro) 1998-06-30
ITMI913171A1 (it) 1992-05-28
GB2250197A (en) 1992-06-03
SK278929B6 (sk) 1998-04-08
RU2062616C1 (ru) 1996-06-27
DE4139017C2 (de) 2000-04-27
CZ281142B6 (cs) 1996-06-12
ATA236791A (de) 1993-09-15
AT397462B (de) 1994-04-25
MY108601A (en) 1996-10-31
CY1800A (en) 1995-02-17
HU205550B (en) 1992-05-28
ITMI913171A0 (it) 1991-11-27
CS360091A3 (en) 1992-06-17
GB2250197B (en) 1994-06-22
HU907654D0 (en) 1991-06-28
JPH04275222A (ja) 1992-09-30
DE4139017A1 (de) 1992-06-04
US5169847A (en) 1992-12-08

Similar Documents

Publication Publication Date Title
IT1261955B (it) Soluzione di farmaci in particolare piroxicam con stabilita' aumentatae senza effetto dannoso sui tessuti e procedimento per la loro preparazione
ATE119040T1 (de) Zentrale cholecystokinin-antagonisten zur behandlung von psychiatrischen krankheiten.
NL300389I1 (nl) Thiofeensulfonamiden die bruikbaar zijn als carbo-anhydraseremmers.
HUT59400A (en) Process for producing thiazole acylamino derivatives substituted with heterocyclic group, as well as pharmaceutical compositions comprising such compounds as active ingredient
ATE121295T1 (de) Augentropfenarzneimittel.
FI893433A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
MA21527A1 (fr) Compositions de piroxicam en solution aqueuse et procede pour leur preparation.
AR029190A1 (es) Composiciones que contienen derivados del acido hidroxieicosatetraenoico y uso para la manufactura de un medicamento en el tratamiento de trastornos del ojo seco
IT1196307B (it) Formulazioni farmaceutiche acquose di piroxicam monoidrato
ES2114117T3 (es) Acidos fenilalcan(en)oicos con actividad antagonista del leucotrieno b4.
SE8400445D0 (sv) Novel pharmaceutical active 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)quinoline derivatives, their production and use
IT1190347B (it) Processo per la preparazione dell'n-dimetilchitosano e suoi impieghi farmacologici
IE40957B1 (en) A 4-0- ,d glucopyransyl-2-deoxystreptamine, a process for its preparing, and compositions incorporating it
ES2100177T3 (es) Compuestos de cefalosporina y su produccion.
DE69332640D1 (de) Pharmazeutische pyridin-derivate
PT87690A (pt) Process for the preparation of acaricide formulations comprising 3,6-bis[2-chlorine-phenyl)-1,2,4,5-tetrazin-(clophenthezine)and oxide of bis[tris(2-methyl-3-phenyl-propyl)tin]oxide of penbutatin
ES2092645T3 (es) Metanoantracenos como antagonistas de dopamina.
KR920700641A (ko) 클로르메티아졸의 신경 변성 예방 및(또는) 치료용 용도
ES456280A1 (es) Un procedimiento para la obtencion de alfa-2,5,9-trimetil- benzo(b)tieno(2,3-f)morfano.
KR910004614A (ko) 벤조티아진 유도체, 그의 제조방법 및 의약품 또는 의약품을 합성하기위한 중간물질로의 응용
SE7510365L (sv) Farmaceutisk beredning och forfarande for dess framstellning
FR2290203A1 (fr) 10,11-dihydro-3-carboxycyproheptadine et son n-oxyde
KR900016130A (ko) 2-피리딜메틸티오 유도체 및 궤양 치료제
DE58909779D1 (de) Alkali- und erdalkalisalze des oxipurinols in amorpher oder kristalliner form als mittel zur behandlung von hyperurikämie und gicht
ITMI932285A1 (it) Disolfuro chinolonico antibatterico

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971128